SPLC indicted in hate scheme

AI & Tech (10)

• SpaceX has entered a deal to acquire Cursor, an AI coding startup, by the end of 2026 for $60 billion or pay $10 billion for collaboration, aiming to create the world's best coding AI.
• Cursor's run rate was $2 billion in February, projected to reach $6 billion by late 2026; this deal could significantly boost SpaceX's projected 2026 revenue of $22-24 billion.
• Chamath Palihapitiya believes the Cursor deal structure prevents SpaceX's S-1 IPO filing from going stale, effectively giving Elon Musk a 50% discount on the acquisition.
• David Sacks argues the Cursor acquisition is complimentary, providing XAI with coding expertise, enterprise clients, and training data, while XAI offers compute resources and a foundation model.
• Chamath Palihapitiya highlighted that much of AI's value is realized in writing software, but enterprises are creating inefficient agents, underscoring the need for strong developer environments like Cursor's IDE.
• David Sacks anticipates a race to develop dedicated, cost-effective cyber models comparable to Mythos, as AI-powered hacking risks drive demand from IT departments and CSOs.
• Chamath Palihapitiya suggests that many vertical SaaS companies are struggling because AI agents make it cheaper and easier for enterprises to spin up internal alternatives, crushing sales and increasing attrition.
• Kevin Warsh argues that AI's deflationary effect is reducing business costs, leading to economic expansion as companies reinvest savings from SaaS budgets, but also notes that traditional inflation metrics are flawed.
• David Sacks identifies a challenge for private equity in SaaS, noting that while public SaaS company valuations are attractive (e.g., Salesforce down 32% in six months), predictable cash flows are jeopardized by AI alternatives.
• Chamath Palihapitiya claims that venture capital and private equity increase SaaS prices to meet return hurdles, making products overpriced and vulnerable to AI-driven cost cutting and unit price reductions.

Business (3)

• Toma Bravo is reportedly handing Medallia, a customer experience SaaS company acquired for $6.4 billion in 2021, to creditors, wiping out $5.1 billion in equity due to rising debt servicing costs.
• David Sacks advises founders against venture debt, as it reduces maneuverability, imposes business covenants, and makes companies brittle, contrasting with equity sales that align more stakeholders.
• Chamath Palihapitiya shared his personal experience with a $420 million credit line almost collapsing, reinforcing his belief that debt makes businesses and individuals vulnerable to market disruptions.

Big Tech (3)

• Tim Cook's 15-year tenure as Apple CEO saw the company's market cap increase over 10x and revenue grow from $100 billion to over $400 billion, driven by improved services mix.
• Jason Calacanis believes Apple under Tim Cook missed key innovations like more practical AR glasses, a killer AI assistant, a self-driving car, a search engine, a television, and consumer robotics.
• Chamath Palihapitiya argues that Tim Cook was an excellent steward, significantly shrinking Apple's share count by 44% and investing in R&D and proprietary silicon, but faces the challenge of adapting to a more heterogeneous device future.

Biology (2)

• A Spanish research team linked the pesticide Picloram, developed by Dow Chemical in 1963, to a scary 80% rise in colorectal cancer in people under 50 over the last two decades.
• David Friedberg notes that epigenomic studies can now detect long-term effects of chemicals like Picloram, which persists in the environment and has a 3x odds ratio for colon cancer in areas of high use.

Health (4)

• John C. Dvorak experienced immediate muscle pain relief using Manuka Gold Pain Relief balm, noting its CBD content and non-sticky, skin-absorbing properties.
• Senator Ron Johnson presented evidence that HHS, CDC, and FDA hid vaccine-related signals for myocarditis and ischemic stroke, despite 20,000 vaccine-associated deaths in 2021. An algorithm reportedly masked adverse events, known to Peter Marks in March 2021.
• A Danish peer-reviewed study by Schmeling and colleagues found 4.2% of vaccine batches caused serious adverse events, while one-third had zero reported issues. Adam Curry argues for vaccine manufacturer liability, as products should not be indemnified if they cause harm.
• A study of 13 million people found flu and pneumococcal shots increased Alzheimer's risk by 50% and dementia risk by 38%. A Cleveland Clinic study also reportedly found flu shots increase flu risk by 27%.

Inflation (1)

• Kevin Warsh attributes inflation to government money printing and excessive spending, advocating for new policy reforms. He favors interest rates over quantitative easing as a monetary tool due to their broader economic impact.

Iran (1)

• Scott Bessent testified that Iran gained $14 billion from sanctions relief and Russia profited $150 million daily from lifted oil sanctions. He defends the relief by arguing it prevented oil prices from reaching $150 per barrel.

Trade (1)

• President Trump revamped Section 232 tariffs on steel, changing the calculation to 50% on the entire product. Brandon Ferris of the Steel Manufacturers Association stated this policy drove $25 billion in investments, adding 4 million tons of capacity and creating tens of thousands of direct and indirect jobs for 87,000 workers.